[go: up one dir, main page]

FR2838645B1 - NOVEL SYNERGISTIC COMPOSITIONS OF VITAMINS, MINERALS AND TRACE ELEMENTS TO STIMULATE THE ELIMINATION OF INTRACELLULAR LIPIDS - Google Patents

NOVEL SYNERGISTIC COMPOSITIONS OF VITAMINS, MINERALS AND TRACE ELEMENTS TO STIMULATE THE ELIMINATION OF INTRACELLULAR LIPIDS

Info

Publication number
FR2838645B1
FR2838645B1 FR0204905A FR0204905A FR2838645B1 FR 2838645 B1 FR2838645 B1 FR 2838645B1 FR 0204905 A FR0204905 A FR 0204905A FR 0204905 A FR0204905 A FR 0204905A FR 2838645 B1 FR2838645 B1 FR 2838645B1
Authority
FR
France
Prior art keywords
vitamins
minerals
stimulate
elimination
trace elements
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0204905A
Other languages
French (fr)
Other versions
FR2838645A1 (en
Inventor
Ravi Shrivastava
Hema Belani
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to FR0204905A priority Critical patent/FR2838645B1/en
Priority to AU2003254759A priority patent/AU2003254759B2/en
Priority to CA2446254A priority patent/CA2446254C/en
Priority to JP2003364492A priority patent/JP2005126379A/en
Publication of FR2838645A1 publication Critical patent/FR2838645A1/en
Application granted granted Critical
Publication of FR2838645B1 publication Critical patent/FR2838645B1/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/06—Preparations for care of the skin for countering cellulitis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A23L33/155—Vitamins A or D
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/07—Retinol compounds, e.g. vitamin A
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/525—Isoalloxazines, e.g. riboflavins, vitamin B2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/34—Copper; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/27—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/671—Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/673—Vitamin B group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Hematology (AREA)
  • Polymers & Plastics (AREA)
  • Birds (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Mycology (AREA)
  • Food Science & Technology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Dermatology (AREA)
  • Pediatric Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FR0204905A 2002-04-19 2002-04-19 NOVEL SYNERGISTIC COMPOSITIONS OF VITAMINS, MINERALS AND TRACE ELEMENTS TO STIMULATE THE ELIMINATION OF INTRACELLULAR LIPIDS Expired - Fee Related FR2838645B1 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
FR0204905A FR2838645B1 (en) 2002-04-19 2002-04-19 NOVEL SYNERGISTIC COMPOSITIONS OF VITAMINS, MINERALS AND TRACE ELEMENTS TO STIMULATE THE ELIMINATION OF INTRACELLULAR LIPIDS
AU2003254759A AU2003254759B2 (en) 2002-04-19 2003-10-17 New synergetic compositions of vitamins, minerals and trace-elements to stimulate the elimination of intra-cellular lipid deposits
CA2446254A CA2446254C (en) 2002-04-19 2003-10-22 New synergetic compositions of vitamins, minerals and trace-elements to stimulate the elimination of intra-cellular lipid deposits
JP2003364492A JP2005126379A (en) 2002-04-19 2003-10-24 New synergetic composition of vitamins, minerals and trace element for stimulating elimination of intracellular lipid deposit

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
FR0204905A FR2838645B1 (en) 2002-04-19 2002-04-19 NOVEL SYNERGISTIC COMPOSITIONS OF VITAMINS, MINERALS AND TRACE ELEMENTS TO STIMULATE THE ELIMINATION OF INTRACELLULAR LIPIDS
AU2003254759A AU2003254759B2 (en) 2002-04-19 2003-10-17 New synergetic compositions of vitamins, minerals and trace-elements to stimulate the elimination of intra-cellular lipid deposits
CA2446254A CA2446254C (en) 2002-04-19 2003-10-22 New synergetic compositions of vitamins, minerals and trace-elements to stimulate the elimination of intra-cellular lipid deposits
JP2003364492A JP2005126379A (en) 2002-04-19 2003-10-24 New synergetic composition of vitamins, minerals and trace element for stimulating elimination of intracellular lipid deposit

Publications (2)

Publication Number Publication Date
FR2838645A1 FR2838645A1 (en) 2003-10-24
FR2838645B1 true FR2838645B1 (en) 2004-05-28

Family

ID=34714413

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0204905A Expired - Fee Related FR2838645B1 (en) 2002-04-19 2002-04-19 NOVEL SYNERGISTIC COMPOSITIONS OF VITAMINS, MINERALS AND TRACE ELEMENTS TO STIMULATE THE ELIMINATION OF INTRACELLULAR LIPIDS

Country Status (4)

Country Link
JP (1) JP2005126379A (en)
AU (1) AU2003254759B2 (en)
CA (1) CA2446254C (en)
FR (1) FR2838645B1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1598063A1 (en) * 2003-10-22 2005-11-23 Ravi Shrivastava Synergic compositions comprising vitamins, minerals and trace elements to stimulate removal of intracellular lipids
FR2883472B1 (en) * 2005-03-23 2010-09-03 Rocher Yves Biolog Vegetale USE OF A CHLOROGENIC ACID AS A SLIMMING ACTIVE INGREDIENT
CA2641420C (en) * 2006-02-03 2013-06-25 Jr Chem, Llc Anti-aging treatment using copper and zinc compositions
US8491937B2 (en) * 2007-02-15 2013-07-23 Wyeth Llc Stability in vitamin and mineral supplements
DE112020001186A5 (en) * 2019-03-11 2022-03-17 Gerhard Hermann dietary supplements

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1356370A (en) * 1972-03-06 1974-06-12 Howard A N Methods and formulations for the treatment of obesity
US4298601A (en) * 1972-03-06 1981-11-03 Technutra, S.A. Method and formulations for the treatment of obesity
JPS5592645A (en) * 1978-12-29 1980-07-14 Yoshiko Saeki Food composition
US5340315A (en) * 1991-06-27 1994-08-23 Abbott Laboratories Method of treating obesity
JPH08259461A (en) * 1995-03-24 1996-10-08 Snow Brand Milk Prod Co Ltd Lipometabolism improver
FR2733418B1 (en) * 1995-04-28 1997-08-01 Ravi Shrivastava NEW COMBINATIONS COMPRISING (-) HYDROXYCITRATE AND INCLUDING IN PARTICULAR NEW THERAPEUTIC ACTIVITIES
FR2747308B1 (en) * 1996-04-11 1998-07-10 Shrivastava Ravi ASSOCIATION OF MARGOUSIER, (-) HYDROXYCITRATE AND CERAMIDES AND COMPOSITIONS CONTAINING THEM
FR2747307B1 (en) * 1996-04-11 1998-07-10 Ravi Shrivastava APPLICATION AS MEDICAMENT OF CERAMIDES AND PARTICULARLY PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
FR2754820B1 (en) * 1996-10-22 1999-10-22 Ravi Shrivastava MAGNESIUM (-) HYDROXYCITRATE, PREPARATION METHOD, APPLICATIONS, AND PARTICULARLY PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
FR2801214B1 (en) * 1999-11-24 2002-09-20 Ravishekhaz Shrivastava USE IN COMBINATION OF NEW SOLID AND NON-SOLID COMPOSITIONS FOR TREATING ABDOMINAL DILATION
AU2002221934A1 (en) * 2000-12-16 2002-06-24 Aventis Pharma Deutschland Gmbh Health promoting compositions

Also Published As

Publication number Publication date
AU2003254759B2 (en) 2009-09-03
FR2838645A1 (en) 2003-10-24
CA2446254C (en) 2012-01-03
AU2003254759A1 (en) 2005-05-05
CA2446254A1 (en) 2005-04-22
JP2005126379A (en) 2005-05-19

Similar Documents

Publication Publication Date Title
EP2105123A3 (en) Skin care compositions containing a sugar amine and a vitamin B3 compound
GEP20063741B (en) Nonaryl-Heterocyclic NMDA/NR2B Antagonists
AU2003270663A1 (en) Human and/or animal fiber-water including encapsulated additives having specific dietary and medical uses
IL163894A (en) 2-hydroxy-3-heteroarylindole derivatives, pharmaceutical compositions comprising them and their uses in the preparation of medicaments
IT1320180B1 (en) NUTRITIONAL AND THERAPEUTIC PREPARATIONS EQUIPPED WITH ANTI-OXIDANT ACTIVITY AND ABLE TO CONTROL THE PONDERAL EXCESSES AND
MY142329A (en) Novel benzo-fused heteroaryl sulfamide derivatives useful as anticonvulsant agents.
AU2003233583A8 (en) Oral lactoferrin in the treatment of respiratory disorders
WO2006017692A3 (en) Novel fenofibrate formulations and related methods of treatment
AU2001268145A1 (en) Compositions for treating eye discomfort containing herbals and/or nutritional supplements and/or minerals and/or vitamins
TNSN04034A1 (en) Combined preparations, containing 1,4-benzothiepine-1,1-dioxide derivatives and other active substances, and the use thereof
FR2838648B1 (en) NEW PERINDOPRIL SALT AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING IT
CY1108138T1 (en) USE OF LUPINOCONGLUTINE FOR TREATMENT OF DIABETES TYPE II
IL174594A (en) MANIPULATED NKT CELLS MODULATING THE Th1/Th2 BALANCE, USES AND THERAPEUTIC COMPOSITIONS THEREOF IN THE TREATMENT OF IMMUNE-RELATED DISORDERS
HUP0401484A3 (en) Use of bibn4096 in combination with other antimigraine drugs for the treatment of migraine and pharmaceutical compositions containing the combination
FR2838645B1 (en) NOVEL SYNERGISTIC COMPOSITIONS OF VITAMINS, MINERALS AND TRACE ELEMENTS TO STIMULATE THE ELIMINATION OF INTRACELLULAR LIPIDS
AU2001275146A1 (en) Compositions for enhancing therapeutic effects containing herbals and/or nutritional supplements and/or minerals and/or vitamins
HUP0400924A3 (en) Use of 2,5-dihydroxybenzenesulfphonic acid derivatives in the production of a medicament used to potentiate the effect of other drugs in the treatment of erectile dysfunction
ITRM20030485A0 (en) COMPOSITION BASED ON CITICHOLINE IN ASSOCIATION WITH VITAMINS FOR THE PREVENTION AND TREATMENT OF EYE DISEASES.
GB2390543B (en) Improvements in and relating to the administration of copper to an animal
DE50011533D1 (en) Preparation for orally administered nutritional and / or medicinal preparations in the form of tablets
TW200501973A (en) Method of improvement of blood circulation
BRPI0411382A (en) 2-aminobenzoyl derivatives
IL164240A (en) 1,3,5 - triazine derivatives, compositions comprising them and uses thereof in the manufacture of medicaments for the treatment of parkinson's disease
AU2001275142A1 (en) Compositions for treating hand and wrist discomfort containing herbals and/or nutritional supplements and/or minerals and/or vitamins
PL1663101T3 (en) Administration form and kit for the oral administration of active substances, vitamins and/or nutrients and use thereof

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20081231

RN Application for restoration
FC Favourable decision of inpi director general on an application for restauration.
ST Notification of lapse

Effective date: 20100630

RN Application for restoration
FC Favourable decision of inpi director general on an application for restauration.
PLFP Fee payment

Year of fee payment: 15

ST Notification of lapse

Effective date: 20171229